This is a preprint.
Sustained Glucose Turnover Flux Distinguishes Cancer Cachexia from Nutrient Limitation
- PMID: 40475657
- PMCID: PMC12139815
- DOI: 10.1101/2025.05.15.654370
Sustained Glucose Turnover Flux Distinguishes Cancer Cachexia from Nutrient Limitation
Abstract
Cancer cachexia is an involuntary weight loss condition characterized by systemic metabolic disorder. A comprehensive flux characterization of this condition however is lacking. Here, we systematically isotope traced eight major circulating nutrients in mice bearing cachectic C26 tumors (cxC26) and food intake-matched mice bearing non-cachectic C26 tumors (ncxC26). We found no difference in whole-body lipolysis and proteolysis, ketogenesis, or fatty acid and ketone oxidation by tissues between the two groups. In contrast, compared to ncxC26 mice ad libitum, glucose turnover flux decreased in food intake-controlled ncxC26 mice but not in cxC26 mice. Similarly, sustained glucose turnover flux was observed in two autochthonous cancer cachexia models despite reduced food intake. We identified glutamine and alanine as responsible for sustained glucose production and tissues with altered use of glucose and lactate in cxC26 mice. We provide a comprehensive view of metabolic alterations in cancer cachexia revealing those distinct from decreased nutrient intake.
Conflict of interest statement
DECLARATION OFINTERESTS The authors declare no competing interests.
Figures
References
-
- Agustsson T., Ryden M., Hoffstedt J., van Harmelen V., Dicker A., Laurencikiene J., Isaksson B., Permert J., and Arner P. (2007). Mechanism of increased lipolysis in cancer cachexia. Cancer Res 67, 5531–5537. - PubMed
-
- Baracos V.E., Martin L., Korc M., Guttridge D.C., and Fearon K.C.H. (2018). Cancer-associated cachexia. Nat Rev Dis Primers 4, 17105. - PubMed
-
- Berriel Diaz M., Rohm M., and Herzig S. (2024). Cancer cachexia: multilevel metabolic dysfunction. Nat Metab 6, 2222–2245. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources